Dabigatran Versus Warfarin With NVAF Who Undergo PCI

Clinical trial NCT03536611 · UNKNOWN

Trial details

NCT number: NCT03536611
Sponsor: Shenyang Northern Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Coronary Artery Disease

Start date: 2018-09-01
Primary completion: 2019-12-31
Enrollment: 1120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.